Cargando…

Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment

Small integral membrane protein 20/phoenixin (SMIM20/PNX) and its receptor GPR173 (G Protein-Coupled Receptor 173) play a role in the regulation of the hypothalamic–pituitary–gonadal axis (HPG). The aim of the study was to determine PNX, FSH, LH, and 17β-estradiol association in women with endometri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulinska, Karolina Iwona, Andrusiewicz, Mirosław, Dera-Szymanowska, Anna, Billert, Maria, Skrzypski, Marek, Szymanowski, Krzysztof, Nowak-Markwitz, Ewa, Kotwicka, Małgorzata, Wołuń-Cholewa, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533597/
https://www.ncbi.nlm.nih.gov/pubmed/34680544
http://dx.doi.org/10.3390/biomedicines9101427
_version_ 1784587352120754176
author Kulinska, Karolina Iwona
Andrusiewicz, Mirosław
Dera-Szymanowska, Anna
Billert, Maria
Skrzypski, Marek
Szymanowski, Krzysztof
Nowak-Markwitz, Ewa
Kotwicka, Małgorzata
Wołuń-Cholewa, Maria
author_facet Kulinska, Karolina Iwona
Andrusiewicz, Mirosław
Dera-Szymanowska, Anna
Billert, Maria
Skrzypski, Marek
Szymanowski, Krzysztof
Nowak-Markwitz, Ewa
Kotwicka, Małgorzata
Wołuń-Cholewa, Maria
author_sort Kulinska, Karolina Iwona
collection PubMed
description Small integral membrane protein 20/phoenixin (SMIM20/PNX) and its receptor GPR173 (G Protein-Coupled Receptor 173) play a role in the regulation of the hypothalamic–pituitary–gonadal axis (HPG). The aim of the study was to determine PNX, FSH, LH, and 17β-estradiol association in women with endometriosis, and the expression of SMIM20/PNX signaling via GPR173. Serum PNX, FSH, LH, and 17β-estradiol concentrations were measured by enzyme and electrochemiluminescence immunoassay. SMIM20/PNX and GPR173 expression in the eutopic and ectopic endometrium was assessed by qPCR and immunohistochemistry. Reduced PNX level, increased LH/FSH ratio and elevated 17β-estradiol concentration were found in patients with endometriosis. No differences in SMIM20 expression were observed between the studied endometria. GPR173 expression was lower in ectopic than in eutopic endometria. SMIM20 expression was mainly restricted to stroma. GPR173 was detected in some eutopic and ectopic stromal cells and in eutopic glandular epithelial cells. Discriminant analysis indicates the diagnostic relevance of PNX and LH/FSH ratio in patients with endometriosis. In women with endometriosis, reduced PNX levels and GPR173 expression may be responsible for HPG axis dysregulation. These new insights may contribute to a better understanding of the pathophysiology of endometriosis and provide the basis for a new strategy for diagnosis and treatment of endometriosis.
format Online
Article
Text
id pubmed-8533597
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85335972021-10-23 Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment Kulinska, Karolina Iwona Andrusiewicz, Mirosław Dera-Szymanowska, Anna Billert, Maria Skrzypski, Marek Szymanowski, Krzysztof Nowak-Markwitz, Ewa Kotwicka, Małgorzata Wołuń-Cholewa, Maria Biomedicines Article Small integral membrane protein 20/phoenixin (SMIM20/PNX) and its receptor GPR173 (G Protein-Coupled Receptor 173) play a role in the regulation of the hypothalamic–pituitary–gonadal axis (HPG). The aim of the study was to determine PNX, FSH, LH, and 17β-estradiol association in women with endometriosis, and the expression of SMIM20/PNX signaling via GPR173. Serum PNX, FSH, LH, and 17β-estradiol concentrations were measured by enzyme and electrochemiluminescence immunoassay. SMIM20/PNX and GPR173 expression in the eutopic and ectopic endometrium was assessed by qPCR and immunohistochemistry. Reduced PNX level, increased LH/FSH ratio and elevated 17β-estradiol concentration were found in patients with endometriosis. No differences in SMIM20 expression were observed between the studied endometria. GPR173 expression was lower in ectopic than in eutopic endometria. SMIM20 expression was mainly restricted to stroma. GPR173 was detected in some eutopic and ectopic stromal cells and in eutopic glandular epithelial cells. Discriminant analysis indicates the diagnostic relevance of PNX and LH/FSH ratio in patients with endometriosis. In women with endometriosis, reduced PNX levels and GPR173 expression may be responsible for HPG axis dysregulation. These new insights may contribute to a better understanding of the pathophysiology of endometriosis and provide the basis for a new strategy for diagnosis and treatment of endometriosis. MDPI 2021-10-09 /pmc/articles/PMC8533597/ /pubmed/34680544 http://dx.doi.org/10.3390/biomedicines9101427 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kulinska, Karolina Iwona
Andrusiewicz, Mirosław
Dera-Szymanowska, Anna
Billert, Maria
Skrzypski, Marek
Szymanowski, Krzysztof
Nowak-Markwitz, Ewa
Kotwicka, Małgorzata
Wołuń-Cholewa, Maria
Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment
title Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment
title_full Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment
title_fullStr Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment
title_full_unstemmed Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment
title_short Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment
title_sort phoenixin as a new target in the development of strategies for endometriosis diagnosis and treatment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533597/
https://www.ncbi.nlm.nih.gov/pubmed/34680544
http://dx.doi.org/10.3390/biomedicines9101427
work_keys_str_mv AT kulinskakarolinaiwona phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT andrusiewiczmirosław phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT deraszymanowskaanna phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT billertmaria phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT skrzypskimarek phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT szymanowskikrzysztof phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT nowakmarkwitzewa phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT kotwickamałgorzata phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment
AT wołuncholewamaria phoenixinasanewtargetinthedevelopmentofstrategiesforendometriosisdiagnosisandtreatment